Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of combining Camrelizumab with Apatinib in patients with gastric cancer and g…
-
EMA approval · 2026-01-16EMA Authorised: Cyramza (ramucirumab) — Eli Lilly Nederland B.V.
The EMA has authorised Cyramza (ramucirumab) for gastric cancer (stomach neoplasms) in the European Union, with Eli Lilly Nederland B.V. as …
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
A clinical trial is evaluating biomarkers PD-L1, tumor mutational burden, MSI, and ctDNA to predict and monitor response to immunotherapy in…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Lead-212 PSV359 Therapy for Patients With Solid Tumors [Phase 1, Phase 2]
Perspective Therapeutics reports that Lead-212 PSV359 Therapy is being studied in Phase 1/2 trials for multiple solid tumors and is currentl…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers [Phase 1, Phase 2]
A Phase 1/2 feasibility trial evaluating the LUM Imaging System for detection of colorectal, pancreatic, esophageal, and gastric cancers is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: IKS014 in Advanced Solid Tumors That Express HER2 [Phase 1]
Phase 1 clinical trial of IKS014 for HER2-expressing advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
This clinical trial update describes the collection of tissue and blood from patients with benign and malignant tumors of the soft tissue an…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: SL-28 for Advanced Solid Tumours [Phase 1, Phase 2]
Clinical trial update for SL-28 in advanced solid tumours across multiple indications; the Phase 1/Phase 2 study is currently not yet recrui…
-
FDA approval · 2026-01-15FDA Approved: OXALIPLATIN — Original Application (Shandong New Time Pharmaceutical Co., Ltd.)
The FDA approved Shandong New Time Pharmaceutical Co., Ltd.'s original application for a generic oxaliplatin injection, enabling its manufac…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based Study
A community-wide population-based study in Lao PDR on Helicobacter pylori infection and gastric diseases has completed, assessing eradicatio…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma [Phase 1]
Phase 1 trial evaluating short-course chemoradiotherapy followed by chemotherapy for resectable gastric cancer; the study is sponsored by MD…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer [Phase 1]
First-in-human phase 1 study of TORL-2-307-ADC in participants with advanced cancer, including gastric cancer, pancreatic cancer, and gastro…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer
This clinical trial entry shows a study evaluating hyperthermic intraperitoneal chemoperfusion (HIPEC) for gastric cancer and related perito…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04) [Phase 3]
This clinical trial update reports the Phase 3 DESTINY-Gastric04 study of trastuzumab deruxtecan for HER2-positive gastric cancer or gastroe…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/2 study of OC-001 in locally advanced or metastatic cancers has been terminated according to its clinical trials registry listing.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma [EARLY_Phase 1]
A phase 1 trial is evaluating the combination of pembrolizumab and lenvatinib for advanced, unresectable, or metastatic gastric cancer and g…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: The Application of Extracellular Vesicle Detection in Gastric Juice Based on Metamaterial Sensing in the Diagnosis of Gastric Cancer and Related Diseases
A clinical trial investigating extracellular vesicle detection in gastric juice using metamaterial sensing for the diagnosis of gastric canc…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201 [Phase 1]
Phase 1 clinical study evaluating the safety and anti-tumor activity of AB-201 in patients with gastric cancer; the study status is not yet …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating Fruquintinib in combination with Trastuzumab and XELOX as first-line thera…
-
CLINICAL_TRIALS other · 2026-01-12Clinical Trial Update: A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a hypoxia-inducible CAR-T cell therapy targeting AXL and CD73 for advanced gastric cancer; the study s…
-
CLINICAL_TRIALS other · 2026-01-12Clinical Trial Update: Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer [Phase 3]
Clinical trial update for a Phase 3 comparison of robotic-assisted vs laparoscopic gastrectomy in cT4a gastric cancer; recruitment has not y…
-
CLINICAL_TRIALS other · 2026-01-12Clinical Trial Update: A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer [Phase 2, Phase 3]
Clinical trial update for a KN026-based combination therapy in HER2-positive gastric cancer (Phase 2/Phase 3), with recruitment not yet star…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Prehabilitation Plus ERAS in Gastric Cancer Surgery [NA]
This update summarizes a completed clinical trial evaluating prehabilitation plus ERAS protocols in gastric cancer surgery.
-
CLINICAL_TRIALS other · 2026-01-09Clinical Trial Update: A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer [Phase 2]
Phase 2 clinical trial update on Adebrelimab plus SHR-A1811/SHR-A1904 with chemotherapy or SHR-8068 for gastric and gastroesophageal junctio…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers [Phase 2]
Phase 2 trial update evaluating trastuzumab deruxtecan for HER2-positive newly diagnosed metastatic esophageal, gastric, and gastroesophagea…